Emiston 8 mg/4 ml (IM/IV Injection)
4 ml ampoule: ৳ 27.00 (1 x 5: ৳ 135.00)
Medicine Details
Category | Details |
---|---|
Generic | Ondansetron |
Company | Ibn sina pharmaceuticals ltd |
Also available as |
Indications
- Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy
- Prevention and treatment of post-operative nausea and vomiting
- Prevention of radiotherapy-induced nausea and vomiting
Description
- Orally dissolving film designed to be applied on top of the tongue
- Dissolves within 20 seconds
- Active ingredient: Emiston base
- Empirical formula: C18H19N3O
- Molecular weight: 293.3
Pharmacology
- Potent, highly selective 5HT3 receptor-antagonist
- Precise mode of action is not known
- Blocks initiation of vomiting reflex
- Acts on neurons in peripheral and central nervous system
Dosage
- Different dosages for adults and pediatric patients
- Dosage adjustment for different types of nausea and vomiting
- Oral solution and oral soluble film options
- Specific dosage for chemotherapy and radiotherapy-induced nausea and vomiting
Administration
- Step by step instructions for administration of oral soluble film
- Emphasis on not chewing or swallowing the film whole
Interaction
- Emiston does not induce or inhibit the cytochrome P-450 drug-metabolizing enzyme system
- Metabolized by hepatic cytochrome P-450 drug-metabolizing enzymes
Contraindications
- Contraindicated in patients known to have hypersensitivity to the drug or any of its components
- Concomitant use of apomorphine
Side Effects
- Frequently reported adverse events: headache, constipation, diarrhea, rash, sensation of flushing or warmth, hiccups, liver enzyme abnormalities
- Rare cases of anaphylaxis, bronchospasm, tachycardia, angina, hypokalemia, shortness of breath
- No evidence of extrapyramidal reactions
Pregnancy & Lactation
- No evidence of carcinogenic effects in animal studies
- No mutagenic effects observed
- No impairment to fertility or harm to fetus observed
- No adequate and well-controlled studies in pregnant women
- Excreted in the breast milk of rats
- Caution advised when administered to nursing women
Precautions & Warnings
- Reported hypersensitivity reactions
- Not a drug that stimulates gastric or intestinal peristalsis
- Should not be used instead of nasogastric suction
- May mask a progressive ileus and/or gastric distension
Use in Special Populations
- Same dosage recommendation for patients with impaired renal function
- Specific dosage recommendation for severe hepatic impairment
- Limited information available about dosage in pediatric patients 4 years of age or younger
- No dosage adjustment needed in patients over the age of 65
Therapeutic Class
- Anti-emetic drugs
Storage Conditions
- Store at temperature not exceeding 30°C
- Dry place
- Protection from light and moisture